The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Immunophenotype and proliferation to predict for response to neoadjuvant chemotherapy in TNBC: Results from BrighTNess phase III study.
 
Otto Metzger Filho
Honoraria - Grupo Oncoclinicas; Roche
Research Funding - Abbvie (Inst); Cascadian Therapeutics (Inst); Eisai (Inst); Pfizer (Inst); Roche/Genentech (Inst); Susan G. Komen for the Cure (Inst)
Travel, Accommodations, Expenses - Grupo Oncoclinicas
 
Daniel G. Stover
No Relationships to Disclose
 
Sarah Asad
No Relationships to Disclose
 
Peter J Ansell
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
Patents, Royalties, Other Intellectual Property - Abbvie
 
Mark Watson
Research Funding - Abbvie (Inst)
 
Sibylle Loibl
Consulting or Advisory Role - AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Lilly (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Seagen (Inst)
Research Funding - Abbvie (Inst); Amgen (Inst); AstraZeneca (Inst); Celgene (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Seagen (Inst); Teva (Inst); Vifor Pharma (Inst)
Patents, Royalties, Other Intellectual Property - Patent Pending EP14153692.0 (Inst)
 
Charles E. Geyer
Consulting or Advisory Role - Celgene; HERON; Myriad Genetics
Research Funding - Merck
Travel, Accommodations, Expenses - Abbvie; AstraZeneca; Genentech/Roche
 
Joyce O'Shaughnessy
Honoraria - Abbvie; Agendia; Amgen; AstraZeneca; Bristol-Myers Squibb; Celgene; Eisai; Genentech; Genomic Health; GRAIL; HERON; Immunomedics; Ipsen; Jounce Therapeutics; Lilly; Merck; Myriad Pharmaceuticals; Novartis; Odonate Therapeutics; Pfizer; Puma Biotechnology; Roche; Seagen; Syndax
Consulting or Advisory Role - Abbvie; Agendia; Amgen; AstraZeneca; Bristol-Myers Squibb; Celgene; Eisai; Genentech; Genomic Health; GRAIL; HERON; Immunomedics; Ipsen; Jounce Therapeutics; Lilly; Merck; Myriad Pharmaceuticals; Novartis; Odonate Therapeutics; Pfizer; Puma Biotechnology; Roche; Seagen; Syndax
Speakers' Bureau - AstraZeneca; Lilly; Novartis
Research Funding - Seagen (Inst)
Travel, Accommodations, Expenses - Abbvie; Agendia; Amgen; Celgene; Eisai; Eisai; Genomic Health; GRAIL; Ipsen; Jounce Therapeutics; Lilly; Myriad Pharmaceuticals; Novartis; Pfizer; Puma Biotechnology; Seagen
 
Michael Untch
Honoraria - See activity statement
Consulting or Advisory Role - See activity statement
 
Hope S. Rugo
Research Funding - Daiichi Sankyo (Inst); Eisai (Inst); Genentech (Inst); Immunomedics (Inst); Lilly (Inst); Macrogenics (Inst); Merck (Inst); Novartis (Inst); OBI Pharma (Inst); Odonate Therapeutics (Inst); Pfizer (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Amgen; Mylan; Novartis; OBI Pharma; Pfizer; Puma Biotechnology; Roche/Genentech; Sanofi
 
Jens Bodo Huober
Honoraria - AstraZeneca; Celgene; Lilly; MSD Oncology; Novartis; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Celgene; Lilly; Novartis; Pfizer; Roche
Research Funding - Celgene (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Celgene; Celgene; Novartis; Pfizer; Roche
 
Mehra Golshan
Consulting or Advisory Role - Abbvie
Research Funding - Breast Cancer Research Foundation
 
William M. Sikov
Honoraria - Celgene; Eisai
Consulting or Advisory Role - Abbvie; Celgene
 
Gunter Von Minckwitz
Stock and Other Ownership Interests - CARA GmbH
Honoraria - Chugai/Roche; Roche/Genentech
Research Funding - Abbvie (Inst); Amgen (Inst); AstraZeneca (Inst); Myriad Genetics (Inst); Pfizer (Inst); Roche (Inst); Vifor Pharma (Inst)
 
Priya Rastogi
Travel, Accommodations, Expenses - Genentech/Roche, Lilly, AstraZeneca
 
David Maag
Employment - Abbvie; Abbvie (I)
Stock and Other Ownership Interests - Abbvie; Abbvie (I)
 
Norman Wolmark
Research Funding - AstraZeneca/MedImmune (Inst)
 
Carsten Denkert
Stock and Other Ownership Interests - Sividon Diagnostics
Honoraria - Amgen; Daiichi Sankyo; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; MSD
Patents, Royalties, Other Intellectual Property - Patent EP 182 09672
 
William Fraser Symmans
Stock and Other Ownership Interests - Delphi Diagnostics; ISIS Pharmaceuticals; Nuvera Biosciences
Consulting or Advisory Role - Almac Diagnostics; Merck
Patents, Royalties, Other Intellectual Property - Intellectual property; Intellectual Property (expired)
Travel, Accommodations, Expenses - Luminex; Merck